These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


803 related items for PubMed ID: 24314876

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR, Bos JD.
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [Abstract] [Full Text] [Related]

  • 24. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, Petropoulou H, Baziaka F, Karagianni V, Stavrianeas N, Giamarellou H.
    Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
    [Abstract] [Full Text] [Related]

  • 25. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP.
    Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
    [Abstract] [Full Text] [Related]

  • 26. A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.
    Gottlieb A, Natsis NE, Kerdel F, Forman S, Gonzalez E, Jimenez G, Hernandez L, Kaffenberger J, Guido G, Lucas K, Montes D, Gold M, Babcock C, Simard J.
    J Invest Dermatol; 2020 Aug; 140(8):1538-1545.e2. PubMed ID: 32004568
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions.
    van der Zee HH, Prens EP, Boer J.
    J Am Acad Dermatol; 2010 Sep; 63(3):475-80. PubMed ID: 20708472
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.
    Lesage C, Adnot-Desanlis L, Perceau G, Bonnet M, Palot JP, Bernard P, Reguiaï Z.
    Eur J Dermatol; 2012 Sep; 22(5):640-4. PubMed ID: 22759562
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.
    Ghias MH, Johnston AD, Kutner AJ, Micheletti RG, Hosgood HD, Cohen SR.
    J Am Acad Dermatol; 2020 May; 82(5):1094-1101. PubMed ID: 31589948
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    Join-Lambert O, Coignard-Biehler H, Jais JP, Delage M, Guet-Revillet H, Poirée S, Duchatelet S, Jullien V, Hovnanian A, Lortholary O, Nassif X, Nassif A.
    J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
    [Abstract] [Full Text] [Related]

  • 34. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
    van der Zee HH, Boer J, Prens EP, Jemec GB.
    Dermatology; 2009 Feb; 219(2):143-7. PubMed ID: 19590174
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients.
    Matusiak L, Bieniek A, Szepietowski JC.
    Br J Dermatol; 2014 Jul; 171(1):170-4. PubMed ID: 24506875
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ustekinumab with Intravenous Infusion: Results in Hidradenitis Suppurativa.
    Romaní J, Vilarrasa E, Martorell A, Fuertes I, Ciudad C, Molina-Leyva A.
    Dermatology; 2020 Jul; 236(1):21-24. PubMed ID: 31288233
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 41.